BioSpace News Archive

MagForce AG to Participate at SNO 2017 Annual Meeting From November 16-19 in San Francisco, USA

MagForce AG today announced its participation in the 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology, SNO 2017, held from November 16-19, 2017, in San Francisco, California, USA.

November 14, 2017
·
5 min read
Specialty Diagnostic Company IQuity Introduces First RNA-Based Blood Test to Identify IBS and IBD

IsolateIBS-IBD uses a simple blood draw to identify, with greater than 90 percent accuracy, if a patient’s RNA profile indicates the presence of IBS or IBD.

November 14, 2017
·
2 min read
Drug Development

BeiGene Expands Global Pivotal Program for BTK Inhibitor BGB-3111

Initiates global Phase 3 trial of BGB-3111 compared to bendamustine and rituximab (BR) in treatment-naïve chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL) patients.

November 14, 2017
·
6 min read
Business

Today’s Jaguar Health Conference Call Moved to 5:45 p.m. Eastern Time

The call is being hosted to review year-to-date sales figures for Jaguar and Napo Pharmaceuticals.

November 14, 2017
·
6 min read
Business

ImmuCell Announces Financial Results for Third Quarter of 2017

During the three-month period ended September 30, 2017, total product sales were just over $2 million compared to just under $2 million during the same quarter of 2016.

November 14, 2017
·
10 min read
Deals

Apellis Pharmaceuticals Announces Closing of its Initial Public Offering

The total gross proceeds to Apellis were approximately $150.0 million, before deducting underwriting discounts and commissions and expenses payable by Apellis.

November 14, 2017
·
2 min read
Business

Acer Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update

Cash and cash equivalents were $8.4 million as of September 30, 2017, compared to $1.8 million as of December 31, 2016.

November 14, 2017
·
7 min read
Business

Marrone Bio Innovations Reports Third Quarter 2017 Financial Results

GAAP revenues grew 31% to $14.8 million for the first nine months of 2017, compared to $11.4 million in the same year-ago period.

November 14, 2017
·
16 min read
Business

UroGen Pharma Reports Third Quarter 2017 Financial Results and Recent Corporate Developments

As of September 30, 2017, cash and cash equivalents totaled $79.2 million.

November 14, 2017
·
8 min read
BioMidwest

Lubrizol LifeSciences and Particle Sciences to Highlight Complex Drug Product Development and Manufacturing at AAPS 2017

The Lubrizol Corporation’s LifeSciences business announces it will highlight the drug product development and manufacturing capabilities of Particle Sciences Inc. at AAPS 2017.

November 14, 2017
·
3 min read